MultiQure Company Description

MultiQure S.A., a biopharmaceutical company, engages in the research and development of biological drugs and medical devices for therapeutic use.

Its therapeutic portfolio in the field of immuno-oncology includes PB003G, which targets the GARP-TGFβ1 complex; PB004, an anticancer drug based on an anti-ROR1 antibody; and PB003A, a therapy that targets the αVβ8 integrin.

The company was formerly known as Pure Biologics S.A. and changed its name to MultiQure S.A. in August 2026.

The company was founded in 2010 and is based in Wroclaw, Poland.

MultiQure S.A.

Country	Poland
Founded	2010
Industry	Biological Products, Except Diagnostic Substances
Employees	7
CEO	Filip Jelen

Contact Details

Address: Szczytnicka 11 Wroclaw, 50-382 Poland
Phone	48 57 000 2829
Website	purebiologics.com

Stock Details

Ticker Symbol	MQR
Exchange	Warsaw Stock Exchange
Fiscal Year	January - December
Reporting Currency	PLN
SIC Code	2836

Key Executives

Name	Position
Filip Jelen	Chief Executive Officer